Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• ForscherInnen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: ANTIMETABOLITES, ANTINEOPLASTIC - THERAPEUTIC USE , . Treffer: 17

2017

Gornicec, M; Wölfler, A; Stanzel, S; Sill, H; Zebisch, A Evidence for a role of decitabine in the treatment of myeloid sarcoma.
Ann Hematol. 2017; 96(3):505-506 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pleyer, L; Döhner, H; Dombret, H; Seymour, JF; Schuh, AC; Beach, CL; Swern, AS; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci. 2017; 18(2): [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Geissler, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
J Hematol Oncol. 2016; 9(6):39-39 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Bohanes, P; Yang, D; Loupakis, F; LaBonte, MJ; Gerger, A; Ning, Y; Lenz, C; Lenz, F; Wakatsuki, T; Zhang, W; Benhaim, L; El-Khoueiry, A; El-Khoueiry, R; Lenz, HJ Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.
Pharmacogenomics J. 2015; 15(3):226-234
Web of Science PubMed FullText FullText_MUG

 

Messina, C; Dellepiane, C; Caroti, C; Sarocchi, F; Ravetti, GL; Boccardo, F; Spina, B A Case of Advanced Mucinous Adenocarcinoma of Bladder in an Adult Patient Treated With Capecitabine-Based Chemotherapy and Review of Literature.
Clin Genitourin Cancer. 2015; 13(5): e365-e368. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2014

Hofmann, H; von Haken, R; Werner, J; Kortes, N; Bergmann, F; Schemmer, P; Jäger, D; Radeleff, B; Schulze-Bergkamen, H Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
Pancreatology. 2014; 14(6):546-549 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Pleyer, L; Burgstaller, S; Girschikofsky, M; Linkesch, W; Stauder, R; Pfeilstocker, M; Schreder, M; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Krippl, P; Geissler, D; Voskova, D; Schlick, K; Thaler, J; Machherndl-Spandl, S; Theiler, G; Eckmüllner, O; Greil, R Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol. 2014; 93(11):1825-1838 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pleyer, L; Germing, U; Sperr, WR; Linkesch, W; Burgstaller, S; Stauder, R; Girschikofsky, M; Schreder, M; Pfeilstocker, M; Lang, A; Sliwa, T; Geissler, D; Schlick, K; Placher-Sorko, G; Theiler, G; Thaler, J; Mitrovic, M; Neureiter, D; Valent, P; Greil, R Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Leuk Res. 2014; 38(4):475-483 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Mairinger, F; Vollbrecht, C; Halbwedl, I; Hatz, M; Stacher, E; Gülly, C; Quehenberger, F; Stephan-Falkenau, S; Kollmeier, J; Roth, A; Mairinger, T; Popper, H Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma.
J Thorac Oncol. 2013; 8(5):644-653 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mairinger, F; Vollbrecht, C; Mairinger, T; Popper, H The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma.
J Thorac Oncol. 2013; 8(8):e80-e82 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Sliwa, T; Egle, A; Linkesch, W; Voskova, D; Angermann, H; Greil, R Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
J Hematol Oncol. 2013; 6(4):32-32 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Hofmann, G; Langsenlehner, U; Langsenlehner, T; Glehr, M; Gerger, A; Absenger, G; Szkandera, J; Fuerst, F; Samonigg, H; Krippl, P; Renner, W Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
Anticancer Res. 2011; 31(4):1373-1377
Web of Science PubMed

 

2006

de Boer, NK; Reinisch, W; Teml, A; van Bodegraven, AA; Schwab, M; Lukas, M; Ochsenkühn, T; Petritsch, W; Knoflach, P; Almer, S; van der Merwe, SW; Herrlinger, KR; Seiderer, J; Vogelsang, H; Mulder, CJ; Dutch 6-TG working group 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.
DIGESTION. 2006; 73(1): 25-31. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Friess, H; Langrehr, JM; Oettle, H; Raedle, J; Niedergethmann, M; Dittrich, C; Hossfeld, DK; Stoger, H; Neyns, B; Herzog, P; Piedbois, P; Dobrowolski, F; Scheithauer, W; Hawkins, R; Katz, F; Balcke, P; Vermorken, J; van Belle, S; Davidson, N; Esteve, AA; Castellano, D; Kleeff, J; Tempia-Caliera, AA; Kovar, A; Nippgen, J A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
BMC CANCER. 2006; 6: 285 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1996

Cunningham, D; Zalcberg, JR; Rath, U; Oliver, I; van Cutsem, E; Svensson, C; Seitz, JF; Harper, P; Kerr, D; Perez-Manga, G Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
Ann Oncol. 1996; 7(9):961-965 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Neumeister, P; Linkesch, W; Höfler, G; Sill, H 2-Chlorodeoxyadenosine as first-line treatment in bronchus-associated lymphoid tissue lymphoma.
Blood. 1996; 87(8):3526-3526 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum